- Home
- CXAI vs AIMD Comparison
CXAI vs AIMD Comparison
Compare CXAI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXAI | AIMD |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | 41 | 44 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 9.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CXAI | AIMD |
|---|---|---|
| Price | $0.25 | $1.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 10.6M | 26.9K |
| Earning Date | 03-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.44 |
| 52 Week High | $1.49 | $4.50 |
Technical Indicators
Market Signals| Indicator | CXAI | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 46.00 |
| Support Level | $0.24 | $1.33 |
| Resistance Level | $0.32 | $1.73 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 55.81 | 37.14 |
Price Performance
Historical ComparisonAbout CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.